Terbium-161 PSMA Therapy Delivers High Tumor Doses With Tolerable Organ Exposure
The largest dosimetry study of terbium-161 PSMA-617 radioligand therapy shows high tumor-absorbed doses with tolerable organ exposure in prostate cancer ...
The largest dosimetry study of terbium-161 PSMA-617 radioligand therapy shows high tumor-absorbed doses with tolerable organ exposure in prostate cancer ...
A new review in the Journal of Advanced Research details how self-assembling delivery platforms built from peptides, polyelectrolytes and natural ...
New ahead-of-print studies in The Journal of Nuclear Medicine showcase immune-cell PET imaging, long-acting radiopharmaceutical therapies, and validated quantitative PET ...
A review examines how silica-reinforced lipid vesicles could improve targeted drug, gene, vaccine and imaging delivery while highlighting unresolved safety ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine